Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

319 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial.
Alton EW, Stern M, Farley R, Jaffe A, Chadwick SL, Phillips J, Davies J, Smith SN, Browning J, Davies MG, Hodson ME, Durham SR, Li D, Jeffery PK, Scallan M, Balfour R, Eastman SJ, Cheng SH, Smith AE, Meeker D, Geddes DM. Alton EW, et al. Among authors: geddes dm. Lancet. 1999 Mar 20;353(9157):947-54. doi: 10.1016/s0140-6736(98)06532-5. Lancet. 1999. PMID: 10459902 Clinical Trial.
Update on gene therapy for cystic fibrosis.
Griesenbach U, Geddes DM, Alton EW. Griesenbach U, et al. Among authors: geddes dm. Curr Opin Mol Ther. 2003 Oct;5(5):489-94. Curr Opin Mol Ther. 2003. PMID: 14601517 Review.
Advances in cystic fibrosis gene therapy.
Griesenbach U, Geddes DM, Alton EW. Griesenbach U, et al. Among authors: geddes dm. Curr Opin Pulm Med. 2004 Nov;10(6):542-6. doi: 10.1097/01.mcp.0000142102.91202.04. Curr Opin Pulm Med. 2004. PMID: 15510064 Review.
Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial.
Alton EWFW, Armstrong DK, Ashby D, Bayfield KJ, Bilton D, Bloomfield EV, Boyd AC, Brand J, Buchan R, Calcedo R, Carvelli P, Chan M, Cheng SH, Collie DDS, Cunningham S, Davidson HE, Davies G, Davies JC, Davies LA, Dewar MH, Doherty A, Donovan J, Dwyer NS, Elgmati HI, Featherstone RF, Gavino J, Gea-Sorli S, Geddes DM, Gibson JSR, Gill DR, Greening AP, Griesenbach U, Hansell DM, Harman K, Higgins TE, Hodges SL, Hyde SC, Hyndman L, Innes JA, Jacob J, Jones N, Keogh BF, Limberis MP, Lloyd-Evans P, Maclean AW, Manvell MC, McCormick D, McGovern M, McLachlan G, Meng C, Montero MA, Milligan H, Moyce LJ, Murray GD, Nicholson AG, Osadolor T, Parra-Leiton J, Porteous DJ, Pringle IA, Punch EK, Pytel KM, Quittner AL, Rivellini G, Saunders CJ, Scheule RK, Sheard S, Simmonds NJ, Smith K, Smith SN, Soussi N, Soussi S, Spearing EJ, Stevenson BJ, Sumner-Jones SG, Turkkila M, Ureta RP, Waller MD, Wasowicz MY, Wilson JM, Wolstenholme-Hogg P; UK Cystic Fibrosis Gene Therapy Consortium. Alton EWFW, et al. Among authors: geddes dm. Lancet Respir Med. 2015 Sep;3(9):684-691. doi: 10.1016/S2213-2600(15)00245-3. Epub 2015 Jul 3. Lancet Respir Med. 2015. PMID: 26149841 Free PMC article. Clinical Trial.
Gene therapy for cystic fibrosis.
Alton E, Smith S, Geddes D. Alton E, et al. Lancet. 1997 Apr 26;349(9060):1249-50. doi: 10.1016/S0140-6736(05)62441-5. Lancet. 1997. PMID: 9130964 No abstract available.
Gene therapy: the case for cystic fibrosis.
Alton EW, Geddes D. Alton EW, et al. J R Soc Med. 1997;90 Suppl 31(Suppl 31):43-6. doi: 10.1177/014107689709031s09. J R Soc Med. 1997. PMID: 9204011 Free PMC article. Review. No abstract available.
319 results